http://www.bing.com/news/search?q=cns%26drug&format=rssSearch resultshttp://www.bing.com/rsslogo.gifhttp://www.bing.com/news/search?q=cns%26drug&format=rssCopyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a08e52b2bcc4858a6cbb3b54ed7ad44&url=https%3a%2f%2fmarkets.businessinsider.com%2fnews%2fstocks%2fcns-drug-delivery-technologies-are-reshaping-alzheimer-s-and-biodefense-research-1036149762&c=10101644678642628815&mkt=en-us(OTCQB: OTLC) (profile) are responding to this challenge with next-generation delivery platforms engineered to circumvent biological barriers and ensure direct, targeted access to the central nervous ...Wed, 13 May 2026 05:38:00 GMTMarkets Insiderhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a08e52b2bcc4858a6cbb3b54ed7ad44&url=https%3a%2f%2fmarkets.businessinsider.com%2fnews%2fstocks%2fcns-drug-delivery-breakthroughs-unlock-significant-biotech-market-opportunities-1036137295&c=13177237980563207175&mkt=en-usBeyond chronic diseases, CNS drug delivery is also a critical factor in biodefense and national security. As traditional drug-delivery approaches continue to face limitations, alternative methods ...Mon, 11 May 2026 05:39:00 GMTMarkets Insiderhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a08e52b2bcc4858a6cbb3b54ed7ad44&url=https%3a%2f%2ffinance.yahoo.com%2fsectors%2fhealthcare%2farticles%2fdrug-farm-present-ophthalmologic-cns-090600458.html&c=2136131040864774199&mkt=en-usDrug Farm today announced ophthalmologic and central nervous system (CNS) findings from its Phase 1b study of DF-003, a first-in-class oral ALPK1 inhibitor, will be presented at the Association for ...Thu, 07 May 2026 02:21:00 GMTYahoo Financehttp://www.bing.com/th?id=ONUT.zeY9nh_xdu75V2Jr4FZ8sg&pid=Newsw={0}&h={1}&c=141024512http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a08e52b2bcc4858a6cbb3b54ed7ad44&url=https%3a%2f%2ffinance.yahoo.com%2fnews%2fandzonbio2-alborada-drug-discovery-institute-131500384.html&c=13833357304942791915&mkt=en-usAndzonBio2 today announced the signature of agreements with the ALBORADA Drug Discovery Institute (ADDI) at the University of Cambridge and Cambridge Enterprise to advance a new class of therapeutics ...Wed, 13 May 2026 06:29:00 GMTYahoo Financehttp://www.bing.com/th?id=ONUT.wDC3cCY1q-5c_Lszd_0j7Q&pid=Newsw={0}&h={1}&c=14400146http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a08e52b2bcc4858a6cbb3b54ed7ad44&url=https%3a%2f%2fwww.genengnews.com%2fresources%2fadvancing-cns-drug-discovery-with-translational-eeg-biomarkers%2f&c=4304707148839417303&mkt=en-usElectroencephalography (EEG) records neuronal activity inside the brain via electrodes placed on the scalp. As a real-time and dynamic method of recording ,EEG offers a direct window on neocortical ...Wed, 06 Jul 2022 17:00:00 GMTGENhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a08e52b2bcc4858a6cbb3b54ed7ad44&url=https%3a%2f%2fwww.news-medical.net%2fnews%2f20260515%2fExiVex-reports-in-human-pharmacokinetic-data-showing-EMRX-101-intranasal-naloxone-approaches-IV-like-peak-plasma-concentrations-with-substantially-faster-Tmax-than-currently-approved-comparator.aspx&c=3683809083608026942&mkt=en-usExiVex Biopharma (formerly EmerRx Biopharma), a clinical-stage pharmaceutical company developing a proprietary dual-chamber intranasal drug delivery platform, today announced in-human pharmacokinetic ...Fri, 15 May 2026 00:44:00 GMTNews-Medical.Nethttp://www.bing.com/th?id=ONUT.iyZeaxrGMrdMy0e-yQA-NQ&pid=Newsw={0}&h={1}&c=14620480http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a08e52b2bcc4858a6cbb3b54ed7ad44&url=https%3a%2f%2fwww.fiercepharma.com%2fpharma%2flipocine-seeks-partner-midphase-nash-asset-pivot-oral-cns-drugs&c=13452601278075269569&mkt=en-usLipocine has formalized its pivot toward central nervous system (CNS) disorders. The biotech, which was already seeking partners for a clutch of other assets, will now focus on the oral delivery of ...Mon, 26 Sep 2022 03:50:00 GMTFiercePharmahttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a08e52b2bcc4858a6cbb3b54ed7ad44&url=https%3a%2f%2fwww.nasdaq.com%2farticles%2fpolyrizon-ltd-reports-promising-preclinical-results-cns-drug-delivery-using-hydrogel-based&c=3395613849982339625&mkt=en-usPolyrizon Ltd., a biotechnology company focused on intranasal drug delivery systems, has reported promising preclinical results for its hydrogel-based Trap & Target (T&T) platform, developed in ...Thu, 12 Jun 2025 04:41:00 GMTNasdaqhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a08e52b2bcc4858a6cbb3b54ed7ad44&url=https%3a%2f%2fwww.raps.org%2fresource%2freport-finds-fda-slow-to-approve-cns-drugs-but-ge.html&c=12148603885743051203&mkt=en-usA new report published by the Tufts Center for the Study of Drug Development (CSDD) validates longstanding data indicating that drugs intended to treat disorders of Central Nervous System (CNS) take ...Tue, 04 Nov 2014 16:00:00 GMTRAPShttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a08e52b2bcc4858a6cbb3b54ed7ad44&url=https%3a%2f%2fwww.medpagetoday.com%2fneurology%2fdementia%2f119452&c=16029701953378394127&mkt=en-usOne in four dementia patients received a potentially inappropriate central nervous system-active drug prescription, Medicare data suggested. However, prescribing rates, notably for benzodiazepines and ...Wed, 14 Jan 2026 16:00:00 GMTMedPage Today